Li, J.; Zhu, Y.; Xie, L.; Ahmadi, S.; Yao, C.; Cui, H.; Kang, X.; Tu, J.; Na, S.
MiR-27b-3p Reduces the Efficacy of Propranolol in the Treatment of Infantile Hemangioma by Inhibiting the Expression of Apaf-1. Biomedicines 2025, 13, 1092.
https://doi.org/10.3390/biomedicines13051092
AMA Style
Li J, Zhu Y, Xie L, Ahmadi S, Yao C, Cui H, Kang X, Tu J, Na S.
MiR-27b-3p Reduces the Efficacy of Propranolol in the Treatment of Infantile Hemangioma by Inhibiting the Expression of Apaf-1. Biomedicines. 2025; 13(5):1092.
https://doi.org/10.3390/biomedicines13051092
Chicago/Turabian Style
Li, Jing, Yifei Zhu, Linyang Xie, Sina Ahmadi, Chonghao Yao, Hao Cui, Xuteng Kang, Junbo Tu, and Sijia Na.
2025. "MiR-27b-3p Reduces the Efficacy of Propranolol in the Treatment of Infantile Hemangioma by Inhibiting the Expression of Apaf-1" Biomedicines 13, no. 5: 1092.
https://doi.org/10.3390/biomedicines13051092
APA Style
Li, J., Zhu, Y., Xie, L., Ahmadi, S., Yao, C., Cui, H., Kang, X., Tu, J., & Na, S.
(2025). MiR-27b-3p Reduces the Efficacy of Propranolol in the Treatment of Infantile Hemangioma by Inhibiting the Expression of Apaf-1. Biomedicines, 13(5), 1092.
https://doi.org/10.3390/biomedicines13051092
